ClinConnect ClinConnect Logo
Search / Trial NCT06363136

Foot Posture, Strength, Performance, and Postural Control in Isolated Gastrocnemius Tightness

Launched by BEZMIALEM VAKIF UNIVERSITY · Apr 9, 2024

Trial Information

Current as of June 09, 2025

Completed

Keywords

ClinConnect Summary

Since the gastrocnemius muscle spans both joints, the kinematics of the ankle joint are influenced by knee flexion. According to Kendall \& McCreary's assessment of normal joint motion angles, when the knee joint is in extension, the passive dorsiflexion angle of the ankle is approximately 20°, and with knee flexion, the angle can approach 30° due to the relaxation of the gastrocnemius. During the midstance phase of walking, the ankle joint allows for 8-10° of dorsiflexion movement. The evaluation of gastrocnemius muscle tightness is conducted using the Silfverskiold method. However, there ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Study group
  • Presence of bilateral isolated gastrocnemius tightness (The test is considered positive when ankle dorsal flexion dorsiflexion increases over a minimum of 10 degrees with the knee flexed than the knee extension.
  • Being between 7-16 years of age
  • Body mass index within normal limits (18.5-24.9 kg/m2) Exclusion criteria
  • Presence of high femoral anteversion, internal tibial torsion, and metatarsus adductus
  • Presence of hypermobility (Beighton score \>4 and above)
  • Leg length discrepancy
  • Presence of any neurological, rheumatic, musculoskeletal, metabolic, and connective tissue disease
  • History of pain, deformity, or surgery associated with the vertebral column and lower extremities
  • Presence of cognitive, mental, and/or severe psychiatric illness
  • Participation in any exercise program or sportive activity in the last six months
  • For the control group, the same inclusion/exclusion criteria will be accepted except that the bilateral Silfverskiold test is negative.

About Bezmialem Vakif University

Bezmialem Vakif University is a prominent academic institution based in Istanbul, Turkey, dedicated to advancing medical research and education. As a clinical trial sponsor, the university leverages its state-of-the-art facilities and a multidisciplinary team of experts to conduct innovative research that aims to improve patient outcomes and enhance therapeutic strategies. Bezmialem Vakif University is committed to adhering to rigorous ethical standards and regulatory guidelines, ensuring the integrity and reliability of its clinical trials while fostering collaboration with global research communities. Through its initiatives, the university seeks to contribute significantly to the field of medicine and public health.

Locations

Istanbul, , Turkey

Patients applied

0 patients applied

Trial Officials

Deniz Tuncer

Principal Investigator

Bezmialem Vakif University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported